Early myocarditis onset after immunotherapy may predict treatment-related fatality
Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely to die of…
Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely to die of…
When new COVID-19 vaccines were first administered two years ago, public health officials found an increase in cases of myocarditis,…
Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19…
A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly…
The risk of developing myocarditis — or inflammation of the heart muscle — is seven times higher with a COVID-19…
A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was…
In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose of…